VSL#3 probiotic differently influences IEC-6 intestinal epithelial cell status and function

Probiotics and prebiotics in ulcerative colitis

(2016) Lauranne A.A.P. Derikx et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered

(2016) Yu Qi Qiao et al.   Journal of Digestive Diseases

When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD

(2016) Esmé van der Gracht et al.   MEDIATORS OF INFLAMMATION

The intestinal epithelial barrier: a therapeutic target?

(2016) Matthew A. Odenwald et al.   Nature Reviews Gastroenterology & Hepatology

Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation

(2016) Benedetta Cinque et al.   PLoS One

Fecal microbiota in pouchitis and ulcerative colitis

(2016) Kai-Yu Li et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis Patients

(2016) Hengameh Chloé Mirsepasi-Lauridsen et al.   Clinical and Translational Gastroenterology

Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics

(2014) Mary Ellen Sanders et al.   Annals of the New York Academy of Sciences

Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis

(2013) Jun Shen et al.   INFLAMMATORY BOWEL DISEASES

Guidelines for the management of inflammatory bowel disease in adults

(2011) C. Mowat et al.   GUT

Wound healing of intestinal epithelial cells

(2011) Masahiro Iizuka   WORLD JOURNAL OF GASTROENTEROLOGY

Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study

(2010) Antonio Tursi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Manufacturing process influences properties of probiotic bacteria

(2010) Łukasz Grześkowiak et al.   BRITISH JOURNAL OF NUTRITION

Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis

(2010) Joshua M. Uronis et al.   INFLAMMATORY BOWEL DISEASES

Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis

(2009) Rudolf Mennigen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

(2009) Ajit Sood et al.   Clinical Gastroenterology and Hepatology

Pouchitis: lessons for inflammatory bowel disease

(2009) Hao Wu et al.   CURRENT OPINION IN GASTROENTEROLOGY

Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function

(2008) Julia B. Ewaschuk et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Epithelial restitution and wound healing in inflammatory bowel disease

(2008) Andreas Sturm et al.   WORLD JOURNAL OF GASTROENTEROLOGY